Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

BACKGROUND: Switch from first to second-line ART is recommended by WHO for patients with virologic failure. Delays in switching may contribute to accumulated drug resistance, advanced immunosuppression, increased morbidity and mortality. The 3rd 90′ of UNAIDS 90:90:90 targets 90% viral suppression f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Infect Dis
Päätekijät: Ssempijja, Victor, Nakigozi, Gertrude, Chang, Larry, Gray, Ron, Wawer, Maria, Ndyanabo, Anthony, Kasule, Jingo, Serwadda, David, Castelnuovo, Barbara, Hoog, Anja van’t, Reynolds, Steven James
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568262/
https://ncbi.nlm.nih.gov/pubmed/28830382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2680-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia